BCTX
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
VKTX
Price
$65.85
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
13 days until earnings call
Ad is loading...

BCTX vs VKTX

Header iconBCTX vs VKTX Comparison
Open Charts BCTX vs VKTXBanner chart's image
BriaCell Therapeutics
Price$0.84
Change-$0.00 (-0.00%)
Volume$1.58M
CapitalizationN/A
Viking Therapeutics
Price$65.85
Change-$0.00 (-0.00%)
Volume$1.52M
CapitalizationN/A
View a ticker or compare two or three
BCTX vs VKTX Comparison Chart
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BCTX vs. VKTX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and VKTX is a Buy.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (BCTX: $0.84 vs. VKTX: $65.85)
Brand notoriety: BCTX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 25% vs. VKTX: 45%
Market capitalization -- BCTX: $37.01M vs. VKTX: $7.02B
BCTX [@Biotechnology] is valued at $37.01M. VKTX’s [@Biotechnology] market capitalization is $7.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 1 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VKTX is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • BCTX’s TA Score: 5 bullish, 5 bearish.
  • VKTX’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than BCTX.

Price Growth

BCTX (@Biotechnology) experienced а -9.37% price change this week, while VKTX (@Biotechnology) price change was +5.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BCTX is expected to report earnings on Oct 27, 2023.

VKTX is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($7.02B) has a higher market cap than BCTX($37M). VKTX YTD gains are higher at: 253.842 vs. BCTX (-85.670). BCTX has higher annual earnings (EBITDA): -32.28M vs. VKTX (-124.38M). VKTX has more cash in the bank: 942M vs. BCTX (936K). BCTX has less debt than VKTX: BCTX (27K) vs VKTX (1.1M). BCTX (0) and VKTX (0) have equivalent revenues.
BCTXVKTXBCTX / VKTX
Capitalization37M7.02B1%
EBITDA-32.28M-124.38M26%
Gain YTD-85.670253.842-34%
P/E RatioN/AN/A-
Revenue00-
Total Cash936K942M0%
Total Debt27K1.1M2%
FUNDAMENTALS RATINGS
BCTX vs VKTX: Fundamental Ratings
BCTX
VKTX
OUTLOOK RATING
1..100
870
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10025
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
5135
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (62) in the Biotechnology industry is somewhat better than the same rating for BCTX (96) in the null industry. This means that VKTX’s stock grew somewhat faster than BCTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (25) in the Biotechnology industry is significantly better than the same rating for BCTX (100) in the null industry. This means that VKTX’s stock grew significantly faster than BCTX’s over the last 12 months.

VKTX's SMR Rating (93) in the Biotechnology industry is in the same range as BCTX (99) in the null industry. This means that VKTX’s stock grew similarly to BCTX’s over the last 12 months.

VKTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as BCTX (51) in the null industry. This means that VKTX’s stock grew similarly to BCTX’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for VKTX (100) in the Biotechnology industry. This means that BCTX’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTXVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 28 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
View a ticker or compare two or three
Ad is loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with SNPX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
-6.82%
SNPX - BCTX
35%
Loosely correlated
+10.33%
MDGL - BCTX
30%
Poorly correlated
-0.26%
AXON - BCTX
30%
Poorly correlated
-0.07%
LSB - BCTX
30%
Poorly correlated
-2.12%
VKTX - BCTX
29%
Poorly correlated
+0.72%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+0.72%
JANX - VKTX
65%
Loosely correlated
-6.31%
DNLI - VKTX
49%
Loosely correlated
+3.02%
LGND - VKTX
47%
Loosely correlated
+2.65%
BEAM - VKTX
44%
Loosely correlated
+1.33%
ALT - VKTX
43%
Loosely correlated
-2.56%
More